Key terms
About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest JNJ news
Yesterday
10:08am ET
J&J to pay $75M to settle Mississipi talc lawsuit, Bloomberg says
Mar 27
3:50pm ET
Judge gives J&J new chance to contest evidence on talc products, Reuters says
Mar 27
8:14am ET
Piper says competitive process could materialize for ShockWave
Mar 26
8:02pm ET
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)
Mar 26
2:23pm ET
Johnson & Johnson in talks to acquire Shockwave Medical, WSJ says
Mar 26
2:20pm ET
ShockWave jumps 8% to $311.29 after WSJ report of J&J talks
Mar 26
2:19pm ET
J&J in talks to acquire ShockWave Medical, WSJ reports
Mar 18
9:19am ET
Arcellx price target raised to $81 from $72 at Needham
Mar 18
7:07am ET
Clearside Biomedical appoints Chong as Chief Medical Officer
Mar 18
6:50am ET
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Aveanna Healthcare Holdings (AVAH)
Mar 15
3:17pm ET
Legend Biotech notes ODAC recommends Carvykti for earlier treatment of myeloma
Mar 15
3:03pm ET
J&J says ODAC recommends Carvykti for earlier treatment of myeloma
Mar 15
12:51pm ET
FDA advisors vote in favor of expanding label of J&J’s Carvykti
Mar 15
12:03pm ET
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
Mar 14
12:15am ET
Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald
Mar 13
8:04am ET
Foot Locker appoints Cindy Carlisle as Chief Human Resources Officer
Mar 08
8:57am ET
Neumora Therapeutics price target raised to $31 from $24 at RBC Capital
Mar 07
2:15pm ET
Johnson & Johnson put volume heavy and directionally bearish
Mar 06
1:22pm ET
Ambrx Biopharma shareholders approve acquisition by Johnson & Johnson
Mar 06
10:07am ET
High Benzene Levels Found in Multiple Brands’ Acne Treatments
Mar 06
9:43am ET
J&J unit applies for Darzalex quadruplet therapy in Europe
Mar 06
9:20am ET
Lab says chemical linked to cancer found in acne creams, Bloomberg reports
Mar 01
4:00pm ET
Johnson & Johnson says Rybrevant-chemotherapy combo approved by FDA
Feb 29
6:32am ET
Barclays Keeps Their Hold Rating on Johnson & Johnson (JNJ)
Feb 28
7:23am ET
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ)
Feb 28
5:38am ET
Hold Rating on Johnson & Johnson Amid Anticipated Varipulse Approval and Afib Market Dynamics
Feb 23
7:23am ET
Legend Biotech gets CHMP recommendation for expansion of Carvykti label
Feb 21
7:25am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 21
4:55am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 21
3:20am ET
Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)
Feb 20
4:28pm ET
Johnson & Johnson: FDA approves sBLA for TECVAYLI for reduced dosing frequency
Today
9:00am ET
Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week
Yesterday
6:15am ET
3 Dividend Stocks That Are Likely to Raise Their Payouts in April
Mar 22
4:25am ET
Want Decades of Passive Income? 2 Stocks to Buy Now.
Mar 21
5:02am ET
Should You Buy 3M Before April 1?
Mar 16
8:15am ET
Meet the "Magnificent Seven" Stock That Pays More Dividends Than Any Other U.S.-Based Company
Mar 16
3:55am ET
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
Mar 13
5:21am ET
3 No-Brainer Stocks to Buy With $300 Right Now
Mar 12
6:53am ET
2 High-Yield Dow Jones Dividend Stocks to Buy Now and Hold Forever
Mar 11
5:35am ET
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
No recent press releases are available for JNJ
JNJ Financials
Key terms
Ad Feedback
JNJ Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
JNJ Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range